Current Environment: Production

Isa F. Ashoor | Education

Undergraduate School

Arabian Gulf University

2003, Manama, Bahrain

Undergraduate School

University of Manitoba

2005, Winnipeg, Canada

Medical School

Arabian Gulf University

2005, Manama, Bahrain

Residency

University of Florida

2010, Gainesville, FL

Fellowship

Boston Children's Hospital

2013, Boston, MA

Isa F. Ashoor | Certifications

  • American Board of Pediatrics (General)
  • American Board of Pediatrics (Nephrology)

Isa F. Ashoor | Professional History

* Dr. Ashoor has medical licenses for a variety of states and can do telehealth visits with patients in those states - MA, CT, ME, NH, LA, VT, RI, and NY

Isa F. Ashoor | Publications

  1. Responding to the workforce crisis: consensus recommendations from the Second Workforce Summit of the American Society of Pediatric Nephrology. Pediatr Nephrol. 2024 Dec; 39(12):3609-3619. View Responding to the workforce crisis: consensus recommendations from the Second Workforce Summit of the American Society of Pediatric Nephrology. Abstract

  2. Effect of pre-emptive rituximab on EBV DNA levels and prevention of post-transplant lymphoproliferative disorder in pediatric kidney transplant recipients: A case series from the pediatric nephrology research consortium. Pediatr Transplant. 2024 May; 28(3):e14743. View Effect of pre-emptive rituximab on EBV DNA levels and prevention of post-transplant lymphoproliferative disorder in pediatric kidney transplant recipients: A case series from the pediatric nephrology research consortium. Abstract

  3. Antibody-mediated rejection in pediatric kidney transplant recipients: A report from the Pediatric Nephrology Research Consortium. Pediatr Transplant. 2024 May; 28(3):e14734. View Antibody-mediated rejection in pediatric kidney transplant recipients: A report from the Pediatric Nephrology Research Consortium. Abstract

  4. Child Health Needs and the Pediatric Nephrology Subspecialty Workforce: 2020-2040. Pediatrics. 2024 Feb 01; 153(Suppl 2). View Child Health Needs and the Pediatric Nephrology Subspecialty Workforce: 2020-2040. Abstract

  5. COVID-19 disease among children and young adults enrolled in the North American Pediatric Renal Trials and Collaborative Studies registry. Pediatr Nephrol. 2024 May; 39(5):1459-1468. View COVID-19 disease among children and young adults enrolled in the North American Pediatric Renal Trials and Collaborative Studies registry. Abstract

  6. Seeking justice, equity, diversity and inclusion in pediatric nephrology. Front Pediatr. 2022; 10:1084848. View Seeking justice, equity, diversity and inclusion in pediatric nephrology. Abstract

  7. Outcomes of granulocyte colony-stimulating factor use in pediatric kidney transplant recipients: A Pediatric Nephrology Research Consortium study. Pediatr Transplant. 2022 05; 26(3):e14202. View Outcomes of granulocyte colony-stimulating factor use in pediatric kidney transplant recipients: A Pediatric Nephrology Research Consortium study. Abstract

  8. Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney Foundation. Am J Kidney Dis. 2022 04; 79(4):570-581. View Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney Foundation. Abstract

  9. The Pediatric Nephrology Workforce Crisis: A Call to Action. J Pediatr. 2021 12; 239:5-10.e4. View The Pediatric Nephrology Workforce Crisis: A Call to Action. Abstract

  10. De novo collapsing glomerulopathy in a pediatric kidney transplant recipient with COVID-19 infection. Pediatr Transplant. 2021 06; 25(4):e14013. View De novo collapsing glomerulopathy in a pediatric kidney transplant recipient with COVID-19 infection. Abstract

  11. A 17-year-old boy with progressive abdominal pain: Answers. Pediatr Nephrol. 2021 Oct; 36(10):3111-3113. View A 17-year-old boy with progressive abdominal pain: Answers. Abstract

  12. A 17-year-old boy with progressive abdominal pain: Questions. Pediatr Nephrol. 2021 Oct; 36(10):3109-3110. View A 17-year-old boy with progressive abdominal pain: Questions. Abstract

  13. Pediatric Immunization Practices in Nephrotic Syndrome: An Assessment of Provider and Parental Knowledge. Front Pediatr. 2020; 8:619548. View Pediatric Immunization Practices in Nephrotic Syndrome: An Assessment of Provider and Parental Knowledge. Abstract

  14. Emerging monitoring technologies in kidney transplantation. Pediatr Nephrol. 2021 10; 36(10):3077-3087. View Emerging monitoring technologies in kidney transplantation. Abstract

  15. Low-Dose Antithymocyte Globulin Has No Disadvantages to Standard Higher Dose in Pediatric Kidney Transplant Recipients: Report From the Pediatric Nephrology Research Consortium. Kidney Int Rep. 2021 Apr; 6(4):995-1002. View Low-Dose Antithymocyte Globulin Has No Disadvantages to Standard Higher Dose in Pediatric Kidney Transplant Recipients: Report From the Pediatric Nephrology Research Consortium. Abstract

  16. Severe Hypertension in a 3-Month-Old Infant. Kidney360. 2020 12 31; 1(12):1464-1465. View Severe Hypertension in a 3-Month-Old Infant. Abstract

  17. Correction to: An adolescent male with acute kidney injury: answers. Pediatr Nephrol. 2020 09; 35(9):1799. View Correction to: An adolescent male with acute kidney injury: answers. Abstract

  18. Correction to: An adolescent male with acute kidney injury: questions. Pediatr Nephrol. 2020 09; 35(9):1797. View Correction to: An adolescent male with acute kidney injury: questions. Abstract

  19. Reassessing Rabbit Antithymocyte Globulin Induction in Kidney Transplantation (RETHINK): An Analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Registry. Transplant Direct. 2020 Sep; 6(9):e598. View Reassessing Rabbit Antithymocyte Globulin Induction in Kidney Transplantation (RETHINK): An Analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Registry. Abstract

  20. An adolescent male with acute kidney injury: Questions. Pediatr Nephrol. 2020 09; 35(9):1621-1622. View An adolescent male with acute kidney injury: Questions. Abstract

  21. An adolescent male with acute kidney injury: Answers. Pediatr Nephrol. 2020 09; 35(9):1623-1624. View An adolescent male with acute kidney injury: Answers. Abstract

  22. Treatment Patterns Among Adults and Children With Membranous Nephropathy in the Cure Glomerulonephropathy Network (CureGN). Kidney Int Rep. 2019 Dec; 4(12):1725-1734. View Treatment Patterns Among Adults and Children With Membranous Nephropathy in the Cure Glomerulonephropathy Network (CureGN). Abstract

  23. Prevalence of Cardiovascular Disease Risk Factors in Childhood Glomerular Diseases. J Am Heart Assoc. 2019 07 16; 8(14):e012143. View Prevalence of Cardiovascular Disease Risk Factors in Childhood Glomerular Diseases. Abstract

  24. Early identification of transplant glomerulopathy in pediatric kidney transplant biopsies: A single-center experience with electron microscopy analysis. Pediatr Transplant. 2019 08; 23(5):e13459. View Early identification of transplant glomerulopathy in pediatric kidney transplant biopsies: A single-center experience with electron microscopy analysis. Abstract

  25. Association of infections and venous thromboembolism in hospitalized children with nephrotic syndrome. Pediatr Nephrol. 2019 02; 34(2):261-267. View Association of infections and venous thromboembolism in hospitalized children with nephrotic syndrome. Abstract

  26. Non-immunologic allograft loss in pediatric kidney transplant recipients. Pediatr Nephrol. 2019 02; 34(2):211-222. View Non-immunologic allograft loss in pediatric kidney transplant recipients. Abstract

  27. Renal Tubular Mitochondrial Abnormalities in Complex II/III Respiratory Chain Deficiency. Fetal Pediatr Pathol. 2017 Jun; 36(3):263-264. View Renal Tubular Mitochondrial Abnormalities in Complex II/III Respiratory Chain Deficiency. Abstract

  28. Bortezomib in the treatment of antibody-mediated rejection in pediatric kidney transplant recipients: A multicenter Midwest Pediatric Nephrology Consortium study. Pediatr Transplant. 2017 May; 21(3). View Bortezomib in the treatment of antibody-mediated rejection in pediatric kidney transplant recipients: A multicenter Midwest Pediatric Nephrology Consortium study. Abstract

  29. Severe West Nile virus meningoencephalitis in a pediatric renal transplant recipient: successful recovery and long-term neuropsychological outcome. Pediatr Transplant. 2016 Sep; 20(6):836-9. View Severe West Nile virus meningoencephalitis in a pediatric renal transplant recipient: successful recovery and long-term neuropsychological outcome. Abstract

  30. Fibroblast growth factor-23 and chronic allograft injury in pediatric renal transplant recipients: a Midwest Pediatric Nephrology Consortium study. Pediatr Transplant. 2016 May; 20(3):378-87. View Fibroblast growth factor-23 and chronic allograft injury in pediatric renal transplant recipients: a Midwest Pediatric Nephrology Consortium study. Abstract

  31. AKI in Children Hospitalized with Nephrotic Syndrome. Clin J Am Soc Nephrol. 2015 Dec 07; 10(12):2110-8. View AKI in Children Hospitalized with Nephrotic Syndrome. Abstract

  32. Sexually transmitted infection screening and reproductive health counseling in adolescent renal transplant recipients: Perceptions and practice patterns. A study from the Midwest Pediatric Nephrology Consortium. Pediatr Transplant. 2015 Nov; 19(7):704-8. View Sexually transmitted infection screening and reproductive health counseling in adolescent renal transplant recipients: Perceptions and practice patterns. A study from the Midwest Pediatric Nephrology Consortium. Abstract

  33. Sexually transmitted infections in pediatric renal transplant recipients: Time to take notice! Pediatr Transplant. 2015 Sep; 19(6):584-7. View Sexually transmitted infections in pediatric renal transplant recipients: Time to take notice! Abstract

  34. Arteriovenous access monitoring with ultrasound dilution in a pediatric hemodialysis unit. Blood Purif. 2015; 39(1-3):93-8. View Arteriovenous access monitoring with ultrasound dilution in a pediatric hemodialysis unit. Abstract

  35. Standardization and cross validation of alloreactive IFN? ELISPOT assays within the clinical trials in organ transplantation consortium. Am J Transplant. 2013 Jul; 13(7):1871-9. View Standardization and cross validation of alloreactive IFN? ELISPOT assays within the clinical trials in organ transplantation consortium. Abstract

  36. Rejection and regulation: a tight balance. Curr Opin Organ Transplant. 2012 Feb; 17(1):1-7. View Rejection and regulation: a tight balance. Abstract

  37. Immune profile of pediatric renal transplant recipients following alemtuzumab induction. J Am Soc Nephrol. 2012 Jan; 23(1):174-82. View Immune profile of pediatric renal transplant recipients following alemtuzumab induction. Abstract

  38. Eruption hematoma as a possible oral sign of infantile scurvy. Pediatr Dent. 2010 Mar-Apr; 32(2):151-5. View Eruption hematoma as a possible oral sign of infantile scurvy. Abstract

BESbswy
BESbswy